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Abstract 
In this paper, we seek to deepen discourse on health data governance beyond the important issues of 
privacy and data security to consider what types of value are potentially afforded by personal health 
information (PHI) data and, importantly, whose values and interests shape governance structures and 
goals toward realizing value. We conducted a discourse analysis of texts addressing PHI data use and 
governance. Through analysis of a broad array of documents using qualitative analysis and guided text 
mining, we identified six overlapping, but distinctive, models for PHI governance. Each model presents an 
array of stakeholders, value to be realized from analysis, assumed stewardship roles, and governance 
structures and goals. This analysis extends consideration of widely shared governance goals, highlighting 
possible issues and conflicts among actors’ values and interests, particularly when data “slip” between 
governing models. We consider policy implications and areas of future research from this analysis. 
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Introduction 
As more business processes are digitized, and as everyday objects are redesigned to include  digital 
sensors, computing power, and communication capabilities, the scope and volume of data generated are 
renewing management attention to long-acknowledged opportunities in and challenges to information 
and data governance (Cohasset Associates 2014). Generally, the business goals of governance are to 
manage and then to “mine” these vast data stores to improve organizational performance (Davenport et al 
2012) or for entrepreneurial, innovative, and competitive opportunities (Lycett 2013). 
Within the healthcare industry, digitized health data hold the promise to improve efficiencies in the 
healthcare industry (Blumenthal 2010) and to “greatly expand the capacity to generate new knowledge” 
(Murdoch and Detsky 2013, p. 1351) to improve delivery and precision of clinical medicine. Enhanced 
storage, processing, and analytics give new views/perspectives into healthcare data down to the personal 
level as well as across populations defined by disease states, geographies, ethnic groups, and so on. Data 
integrity, privacy, and security of personal health information (PHI) are subject to government regulation 
due in large part to the potential harm to individuals or groups, depending on how these data are used 
(e.g., to discriminate based on health status). Thus, along with the opportunities for new value to be 
mined from accumulating health data stores, there are growing concerns about how to protect privacy and 
security of these valuable data resources (Rosenbaum, 2010; Belanger 2015). 
This has inspired much discourse about responsibilities for the security of health data, protection of 
privacy from unauthorized uses (without necessarily addressing what constitutes “authorized” access), 
and managing the integrity of the data by ensuring it is accurate and complete. This, in turn, has 
revitalized discourse on data governance and the related concept of data stewardship (e.g., Rosenbaum 
2010; Hripcsak et al 2014). These discourses range from a plethora of practical advice (i.e., how to make 
data governance work) to less frequent discussions of philosophical and societal implications of data 
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stewardship. Joining in this latter approach, we argue that in addition to “how to” questions, we need to 
consider the “why” and “for whom” questions that are the essence of data stewardship and governance. 
In this paper, we seek to broaden and deepen the discourse on health data governance and stewardship 
beyond important issues of privacy and data security to consider what types of value are potentially 
afforded by PHI data and, importantly, whose values and interests shape governance structures and goals. 
To do so, we conducted a discourse analysis of texts that address PHI data use and governance. By reading 
and analyzing a broad array of documents and using qualitative analysis and guided text mining, we 
identified six overlapping but distinctive models for personal health data governance. Each model 
presents an array of stakeholders, value to be realized from analyzing data, assumed stewardship roles, 
and governance structures and goals. This analysis extends consideration of widely shared governance 
goals (privacy and security) to highlight possible issues and conflicts among actors’ values and interests, 
particularly when PHI data “slip” beyond one governing model to other models. 
Background and motivation 
As data are increasingly understood as a strategic resource, organizations have implemented data 
governance programs to create business value from data assets (Khatri and Brown 2010). Data 
governance relates to the management of enterprise data, including issues of data aggregation and 
integration, data integrity, security, and privacy. Complying with regulatory requirements (such as the 
Sarbanes-Oxley Act of 2002) place constraints on practices of data governance. The information systems 
field has long acknowledged these opportunities and challenges of managing data stores in order to reuse 
data for a wider scope of business analysis (i.e., “business intelligence”). Data warehousing developed as a 
technical and organizational approach to aggregate and manage data generated within discrete 
transactional systems and diverse business functions and units (e.g., Inmon 1996; Kimball and Ross 
2013). Inter-organizational data management and exchange among supply chain network partners have 
focused on technology standards (such as EDI, or electronic data exchange) and organizational 
arrangements (e.g., Elgarah et al 2005). Now, with an exponential increase in the volume and variety of 
“big data”, researchers are again focusing on information and data governance issues (George et al 2014). 
Digitization of health-related data is progressing rapidly, generating highly coveted data sources and 
robust discussions of data governance (Diamond et al 2009; Kanaan and Carr, 2009; Rodwin, 2009; 
Rosenbaum, 2010; Elliott et al 2013; Hripcsak et al 2014; Ross et al 2014). Data governance entails the 
processes and institutional structures for managing a data store (or data domain), including policies for 
granting accessing (to who, how) and appropriately using data, whereas data stewardship implements 
governance goals by acquiring, storing, and granting access to data; stewardship also conveying a 
fiduciary (trust) relationship between the steward and the individuals or entities whose data are governed 
(Rosenbaum et al 2010, pg. 1444). Government policymakers’ attempts to regulate health data exchange 
and governance among industry actors (e.g., healthcare providers) highlights pervasive issues with access 
rights, ownership, data standardization, privacy, and security of health data (Rosenbaum, 2010). 
High expectations for the societal and economic value that could be realized by using health data for 
health system improvements and innovation add organizational energy and resources, as well as societal 
pressure, on healthcare sector stakeholders to resolve governance issues in order to realize these values 
from healthcare data (Cohasset Associates 2014; Hripcsak et al 2014). Nonetheless, realizing effective 
governance of healthcare data remains an elusive goal. Rosenbaum (2010) observes that, “An intense 
struggle over health information access has been a hallmark of the health care system for decades … 
Opponents raise a host of concerns, citing patient privacy, the confidential nature of the 
patient/professional relationship, and health information security. Naturally, opponents also are 
focused on their own interests, given the potentially deleterious impact of uncontrolled data access on 
their liability under a host of civil and criminal laws, as well as on their competitive market position” (p. 
1443). This latter point highlights two related issues, i.e., what are types of value that might be derived 
from access to and use of a health data store, and which stakeholder values and interests guide the design 
of governance and stewardship policies, structures, and goals? 
Critiquing the aggregation of digital Internet trace data, Zuboff (2015) posits that “surveillance 
capitalism” creates economic value for technology firms and their clients (such as advertisers) in the form 
of profits, market share, and competitive advantage, which may sacrifice individual privacy and autonomy 
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of the individuals subject to invisible surveillance. On the other hand, Jin and Feenberg (2015) argue that 
ICTs provide affordances for value creation by and among community members themselves that can alter 
such disparities. These questions about value afforded by data and stakeholder values and interests are 
relevant to health data governance. Beyond clinical and organizational data, many new sources and types 
of personal health data are now collected and aggregated (e.g., consumer-generated data from fitness 
trackers and de-identified prescription records collected by data aggregators). In the U.S., these latter 
types of personal health data are not subject to government regulations such as the Health Insurance 
Portability and Accountability Act (HIPAA). These data may also be used in ways that are invisible to 
individuals who are the subjects of those data and who do not benefit (and might be harmed) by their use 
(Office of the National Coordinator for Health Information Technology 2015a; Tanner 2016). 
To investigate possible issues related to value afforded by PHI data and stakeholder values and interests 
in data governance requires that we systematically examine existing health data governance models as 
well as models emerging as new sources of PHI data become available. As a first step, in this paper we 
report our analysis of six overlapping, but distinctive, models and the dimensions that characterize each. 
Methods 
We conducted a discourse analysis of texts related to PHI data governance using an iterative, grounded 
approach involving qualitative analysis and coding along with software-assisted text mining. For initial 
coding, we used WordStat 7.13 text mining software to identify patterns in the documents and then 
conducted manual coding using QDA Miner 4.133 software to refine and extend coding categories. 
To create the corpus for analysis, we selected documents related to data governance and stewardship, 
particularly those related to health data and PHI data specifically. We sought documents that 
demonstrated perspectives of a variety of relevant stakeholders, i.e., academics, government agencies 
(federal and state), citizens’ groups, corporations, journalists, not-for-profit lobbyists, and health-care 
industry consultants. Documents included published journal articles available in indexed databases, as 
well as white papers, policy documents, websites, and blogs available on the Internet. Search and retrieval 
was an iterative process, guided by the ongoing analysis. It was not our intention to amass all relevant 
works or a statistically representative sample of documents, but to ensure that the corpus was rich and 
represented the various viewpoints of key stakeholders (see Davidson et al 2015 for a similar approach.) 
Because the field is rapidly changing due to technology advances and regulatory action, we primarily 
focused on documents published in the past five years (87.5% of the corpus was published in 2011 or later, 
and the remainder were seminal documents). In total, we selected 160 documents for inclusion. 
We prepared the corpus for analysis by cleaning the data (i.e., removing any unnecessary information and 
designating stop words). This was accomplished in WordStat 7.13. Categories were then defined by the 
researchers using WordStat's dictionary tool. Once the data had been properly prepared in WordStat, we 
used the keyword in context (KWIC) feature to perform topic extraction, identify codes by machine- 
guided review of the text and import them into QDA Miner 4.133 for further analysis. Documents were 
then manually coded (in QDA Miner 4.133) to refine and extend coding categories from the text mining 
steps. By examining data dimensions resulting from these steps (data domain, actors, stakeholders, value 
afforded by data to stakeholders, governance structures, governance goals) we identified the six  (6) 
models of data governance for PHI data discussed below. Our analysis highlights the relationships and 
potential conflicts among types of value from PHI data and the values shaping these governance models. 
Findings 
We present findings by first explaining the dimensions that characterize and differentiate governance 
models and then elaborating the six (6) models we identified. 
Data Domains: PHI data with personally-identifying (or potentially identifying) characteristics 
include: medical history data; clinical data collected in EHR systems of hospitals, physicians, and 
laboratories; pharmacy prescription data; patient-generated health data from medical devices (such as a 
glucose monitor) or general purpose activity tracker; and medical expense claims data. Other PHI data 
domains are created by analyzing data not directly connected to health status, but health status can be 
inferred analytically. These data can be characterized as consumer-generated health data, for instance 
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trace data from Internet search activities, credit card purchases and online shopping, or 
geospatial/location data. Such data are used to generate personal health profiles and, if these profiles 
correlate with a commercially desirable outcome, may lead to more or less favorable treatment for those 
with certain health conditions, even when data are de-identified from specific individuals (Libert 2015). 
Value afforded by PHI data: Health data value arises in how these data can be used to create 
direct sources of value to stakeholders. The value afforded is not limited to initial use, as data can be 
reused for multiple other purposes. Moreover, how data are governed, and the stewardship practices for 
aggregating and permitting access to data, can afford new forms of value for different stakeholders or 
inhibit realization of value by others. For instance, healthcare providers that adopt EHR use the digitized 
clinical data for day-to-day practices and, importantly, to justify and submit payment claims to a health 
insurer (in the U.S.) or other funders. These data, collected for operational and revenue-generating 
purposes, could be aggregated and mined to identify system-wide opportunities to improve organizational 
efficiencies to benefit various payers (e.g., patients, insurers). Realizing these latter forms of value may 
compromise the self-interest of the provider organization, if inefficiencies have been compensated (e.g., 
payment for duplicate services). Table 1 illustrates key value types identified through the analysis. 
 
Code Description Stakeholders 
primarily affected 
Example 
Individual 
health 
enhancement 
Using PHI data to 
improve one’s own 
health and 
wellness 
Individual “These wearable devices have been adopted by 
individuals seeking to enhance their personal 
fitness through increased personal health 
surveillance and social connections with others 
using the devices” (Chiauzzi et al 2015, p. 2) 
Organizational 
improvement 
Using PHI data to 
improve efficiency, 
effectiveness, 
marketability, etc. 
The organization 
that generates the 
data source 
“The data translate into billions of dollars for 
many types of enterprises, in the form of new 
markets, new products, and cost-savings” 
(Sarasohn-Kahn 2014, p. 3) 
Evidence- 
based 
healthcare 
Using PHI data to 
assess and specify 
best clinical 
treatments 
Patients; Health 
service providers 
“So there would seem to be increased 
opportunities for analyzing large volumes of 
composite data to improve quality, comparative 
effectiveness, and public health” (Diamond et al 
2009, p. 455) 
Population 
health 
management 
Using PHI to 
manage delivery of 
health services to 
identified groups 
to reach 
improvement goals 
Patients in the 
population group; 
Health service 
providers (with 
value-based 
reimbursement) 
“It is clear that the context of DDD [digital disease 
detection] differs in significant ways from other 
types of big data activity concerned with health. 
DDD has a public health function, aiming 
ultimately to improve health at the population 
level” (Vayena et al 2015, p. 3) 
Health system 
improvement 
Using broadly 
aggregated PHI to 
reduce costs and to 
improve quality 
and safety of 
health services 
Society at large 
(improved health 
reduced tax 
burdens); 
Health system 
funders (e.g. 
government) 
“Use of these health data beyond direct clinical 
care of individuals from whom the data were 
collected is essential to enhance healthcare 
experiences for individuals, improve healthcare 
quality and outcomes for individuals and 
population groups, and reduce system-wide 
healthcare costs” (Hripcsak et al 2014, p. 206) 
Evidence- 
based pricing 
Using PHI data to 
justify prices of 
health care 
services, 
medications, etc. 
Pharmaceutical 
firms; 
Health system 
providers 
“Consumers’ health scores could be useful for 
providers and payers as they move to value-based 
payment. A McKinsey & Company analysis points 
to a trillion-dollar savings over the next decade by 
tying payments more aggressively to outcomes” 
(Sarasohn-Kahn 2014, p.8) 
Monetization Aggregating PHI 
data for resale to 
other 
organizations 
3rd party 
aggregators; 
Clients or partner of 
aggregators 
“In turn, IMS sells insights from its more than half 
a billion patient dossiers mainly to drug 
companies. So-called health care data mining is a 
growing market and one largely dominated by 
IMS” (Tanner 2016, ¶ 1) 
Table 1. Value Types Afforded by PHI Data 
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Stakeholders: Stakeholders are individuals or collective actors such as organizations that have some 
“stake” in the potential value that PHI data represents, and who are affected in some manner by data 
access and use policies and practices. Some stakeholders are central actors in a governance model, such as 
an organization that generates the digitalized PHI data. Other stakeholders may not actively generate or 
use the PHI data but are influenced by data use, for instance, individuals whose prescription data are 
aggregated and sold to pharmaceutical firms. Among the many stakeholders we identified are individual 
subjects (e.g., as patients or consumers), the organizations that create data (e.g., hospitals, physician 
practices, and third-party payers such as insurers), and IT vendors that supply health IT (HIT) systems or 
support PHI applications or platforms (such as Apple Health). Regional health industry organizations, 
government policymakers, medical researchers, and community health organizations are also key 
stakeholders, as are third-party health data aggregator firms and their clients. 
Governance structures: The governance structure category includes sub-categories such as 
policies, regulations, organizational units, practices, and technologies that reflect and carry out 
governance goals. For instance, HIPAA regulations are policy structures that specify how identifiable PHI 
must be managed and the entities that are responsible for doing so (e.g., health service providers, 
pharmacies, insurance companies). A Data Access Committee (organizational structure) may be 
established to evaluate and authorize legitimate requests for PHI for research purposes. Algorithms for 
personal de-identification (technology structures) can be used to remove PHI data from HIPAA oversight. 
An important governance structure is the steward role and responsibilities for implementing governance 
goals relative to a data domain or a specific data store. One commonly advocated steward role is the 
“neutral third party” organization that is charged with aggregating data from entities that create specified 
digitalized PHI, possibly harmonizing and assuring data quality and integrity, and enforcing policies for 
access to the data. Within organizations this role may be played by a data warehouse support unit in the 
IT or clinical informatics department, whereas for inter-organizations data exchange the steward role may 
be carried out by a neutral third-party entity, such as a health information exchange (HIE). 
Governance goals: This category includes sub-categories representing the values-based objectives 
and intentions for governing a data domain using an array of governance structures. Protecting the 
privacy of individual health data is one of the most frequently discussed goals of PHI data governance. A 
related goal is to secure PHI data from unauthorized access, whether through a data breech or by 
stakeholders who are not authorized to view PHI (e.g., in the U.S., employers cannot view their 
employees’ health data.) Table 2 highlights some of the most commonly articulated goals we identified. It 
is important to realize that some governance goals are aimed at maximizing the value afforded by PHI 
data for specific stakeholders. Thus, the Rosenbaum (2010) quote cited earlier highlighted potential 
conflicts among stakeholders with an interest in PHI. For instance, a data aggregator may desire opacity 
on how they process and use putatively de-identified pharmacy data whereas third-party payers may 
desire transparency to understand how pharmaceutical firms use data to increase profits (Tanner 2016). 
 
By comparing across these dimensions, we identified the following prototypical models of PHI data 
governance evident in various stakeholders’ discussions of PHI data uses and management. 
Organizational PHI data governance: This model is well known in the IS field, as many businesses 
generate data through their transactional systems and aggregate data for enterprise-wide analysis (Khatri 
and Brown 2010; Kimball and Ross 2013). In healthcare settings, the governance structures typically 
include centralizing data stores via a data warehouse or data lake with the organization performing data 
stewardship functions (Elliott et al 2013). HIPAA regulation and legal rights to PHI data stores are 
externally sourced governance structures. The key stakeholders in this model are health providers, 
insurance companies and other third party payers that generate transactional PHI-related data. Primary 
values types from PHI data include organizational improvement and evidence-based pricing, whereas 
data governance goals include demonstrating compliance and maintaining trust, providing efficient data 
access, and data mining for innovation and quality patient care. 
Inter-organizational PHI data governance: Healthcare services often require coordination across 
organizations, and hence the exchange of PHI data housed within organizational systems. Inter- 
organizational data governance models are aimed at facilitating PHI data exchange between organizations 
to realize the data’s value to enable health system improvements (e.g., reducing medical errors, 
eliminating redundancies in patient care). A key example is a health information exchange (HIE) 
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organization designed to enable secure PHI data transfer and sharing among healthcare service providers. 
As a (neutral) trusted third party, the HIE entity serves as the data steward to ensure data quality, 
integrity, security, and access. Other relevant governance structures include HIPAA regulations and data 
harmonization, aggregation, storage, and access technologies. Governance goals include efficient access 
(for authorized individuals), regulatory compliance, and a trusted mechanism for data exchange. 
 
Code Sub-codes Description Example 
Compliance Quality reporting, Data 
retention 
Supporting activities 
and processes that 
enable regulatory 
compliance related 
to PHI 
“Besides cost imperatives, compliance issues 
related to legislation, such as HIPAA, SOX and 
Basel II, determine how organizations must 
deal with the lifecycle of data, its retention and 
archival” (Khatri and Brown 2010, p. 151) 
Efficiency Cost reduction/ control, 
Systems integration, 
Risk reduction, 
standardization 
Making PHI data 
available for various 
uses with less effort 
to compile data. 
“Information management and control is an 
undeniable healthcare imperative” (Cohasset 
Associates 2014, p.1) 
Innovation Data mining, forecasting 
health issues 
Providing access to 
PHR data to enable 
new insights or 
approaches. 
“Also, with the massive interest in big data 
across insurance, financial services and other 
markets, capital is flooding into this segment of 
the software business, which is leading to a 
relentless stream of innovation and pseudo- 
innovation” (Liebman 2015, p. 15) 
Data-driven 
engagement 
Patient engagement, 
Giving voice, Sharing 
data analysis, Global 
justice 
Providing 
stakeholders access 
to and control over 
their PHI data 
“It’s time to give the patients who are the 
sources of the data a voice in this discussion” 
(Tanner 2016, ¶ 6) 
Quality 
patient care 
Improved patient care 
(outcomes), Data quality 
Enabling analysis of 
healthcare outcomes 
with PHI access 
“Improve the quality and safety of patient care 
confirmed as a key driver by 95% of survey 
respondents” (Cohasset Associates 2014, p.8) 
Trust Privacy, Security, 
Transparent data 
management, Opacity, 
Access, Access 
restrictions 
Engender trust 
among stakeholders 
that PHI data are 
managed according 
to policies and 
stated goals. 
“Mechanisms to ensure trust are critical for 
addressing the privacy of individuals whose 
records are being accessed and individuals or 
organizations that share health data. Ensuring 
public trust is critical in systems that share 
sensitive information” (Diamond et al 2009, p. 
456) 
Table 2. PHI Data Governance Goals 
 
Public Good PHI data governance: This model promotes access to aggregated, (often) de-identified 
patient data to researchers to innovate or identify efficiencies in health systems delivery. This perspective 
acknowledges scientific advancements and innovations may occur through analysis of PHI data governed 
explicitly to do so (e.g. Hripcsak et al 2014; Rosenbaum 2010). For example, Ross et al (2014) and Holmes 
et al (2014) review the HMO Research Network’s (HMORN) virtual data warehouse (VDW) uniting 17 
health care systems across the United States and providing data for thousands of research projects to 
date. Key stakeholders in this model include the public, medical and public health researchers (who mine 
the data), and healthcare service providers. In this model, the stewardship role varies among trusted third 
parties. Several governance structures identified in the analysis include technologies for data aggregation, 
organizational structures such as data access committees, PHI de-identification practices and techniques, 
and HIPAA regulations. Governance goals include efficient access for researchers and data mining for 
innovation in health services. However, the public interest in governing PHI data to realize value (e.g., 
health system improvement) can conflict with the interests of private organizations in profiting (or 
profiteering) from aggregated PHI (Rodwin 2009; Tanner 2016). 
Community Health PHI data governance: This model focuses on grassroots efforts promoting 
community health. The value of data is population health management (and improvement) within a 
particular community (geospatial or online). For example, PatientsLikeMe is an online network of 
7 
Post-print 
 
Winter, J. S., & Davidson, E.  (2017). “Investigating values in personal health data governance models.” 23rd Americas 
Conference on Information Systems (AMCIS). August 2017, Boston, MA. 
 
 
patients with various medical conditions. Members connect with others with similar conditions to get 
advice and support (Bradley et al 2016). The platform also serves to conduct real-time research via clinical 
reporting tools that allow aggregate data to be analyzed to better improve health outcomes. Community 
members produce self-reported medical data, and the organization’s research team uses these data for 
scientific and commercial medical research (Tempini 2014). The platform enables sharing of personal 
health data to improve one’s own medical condition, help others with similar conditions, and transform 
medicine, enriching the good of society at large (Eichler et al 2016). As with the Inter-organizational and 
Public Good models, the stewardship role varies among trusted third parties, and governance structures 
may also vary greatly. For instance, PHI may or may not be de-identified, and community members may 
voluntarily cede HIPAA protection (at least for their own PHI data). Governance goals typically center on 
data-driven engagement, for instance addressing health disparities, engaging and giving voice (to 
patients), forecasting community health issues, and sharing data analysis. 
Personal PHI data governance: This model is based on the belief that individuals will become more 
engaged in their own health when they have access to personal health data (Davidson et al 2015) and has 
gained momentum with growing prevalence of wearable devices and mobile software apps that monitor 
specific health conditions (e.g., glucose monitors) and gather data such as body temperature, heart rate, 
activity level, and user-input information about diet (sometimes termed the “quantified self”). With 
personal health record models, individuals are granted some steward roles over their own PHI housed in 
providers’ clinical systems (Davidson et al 2015), whereas data generated by the individual through direct 
data entry or use of wearables are typically housed on an IT vendor’s cloud-based infrastructure (e.g., 
Fitbit or Apple Health). The key stakeholders for this model are individuals and IT vendors, and they 
share stewardship along with any affiliates either party shares the data with. The key values underlying 
the data are personal health enhancement (for individuals) (Chiauzzi et al 2015) and monetizing PHI data 
(for the IT vendor). Governance structures include basic security, privacy policies and, in some cases, de- 
identification. Dolan (2014) also highlights the role of software and physical devices as a governance 
structure – the software, once installed on phone and connected to devices, can operate independently, or 
under the control of the user (consumer). Governance goals typically focus on efficient data access, data- 
focused engagement and trust in data stewardship practices (as stated in privacy policies). 
Aggregator PHI data governance: In this model, data are either gathered from trace data activities 
performed on the Internet or via mobile phones, or purchased from healthcare sector or other 
organizations. Typically, these data are not personally identifiable or have been de-identified prior to sale, 
and thus are not covered by HIPAA. The types of value afforded by these data vary considerably. For 
instance, de-identified PHI data can be aggregated, combined with other data sources, and used to inform 
medical research (Sarasohn-Kahn 2014). Health data can also be purchased, aggregated and analyzed, 
and sold to other organizations, generally in the healthcare industry (Tanner 2016). Under this model, the 
aggregator firm and its clients are primary stakeholders, with others such as individuals indirectly 
influenced by the actions taken based on aggregated data (such as denying health insurance coverage). 
The stewardship role is managed by the aggregator firm and any associates it shares data with. The values 
realized through the data are monetization and evidence-based pricing. Governance structures include 
use of de-identified PHI, data aggregation technologies, and intellectual property claims. Governance 
goals include data mining, forecasting health issues, innovation, and intellectual property protection. 
Discussion 
Through a process of discourse analysis, we identified six prototypical models of PHI data governance 
evident in publicly available discussions of health data, their value and potential applications within the 
healthcare industry, and policy issues related to health data governance and stewardship. Figure 1 depicts 
the six models discussed above, and Tables 1 and 2 summarize key aspects of our findings on the types of 
value afforded by PHI and PHI governance goals. This analysis deepens our understanding of healthcare 
governance issues beyond discussions of privacy and security of personal health data and extends 
consideration of health data value beyond general claims about improvements to, or even transformation 
of, the healthcare sector (Blumenthal 2010). We suggest that the values and interests that underlie health 
data governance policies and structures are often depicted as unproblematic and widely shared. While it 
is true that many stakeholders in the healthcare industry value health data for their potential to inform 
health system improvements, population health, and evidence-based medicine, there are also potential 
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conflicts between the values and interests that underlie various models for PHI data governance, and 
therefore in the value that can be realized or derived from governing PHI data sources. 
 
Figure 1. Data governance models in healthcare 
For instance, both the Public Good and the Aggregator models are based on aggregating data across 
multiple sources to enhance the value realized from PHI through data mining and analysis. However, in 
the Public Good model, underlying values and interests that influence how PHI data are governed and 
which entities assume stewardship relate to realizing health system improvement through PHI data. 
Improvements entail promoting efficacy and cost-effectiveness of treatments and reduction of excess 
healthcare costs. In contrast, under the Aggregator model, profitability (or profiteering) by monetizing 
health data entails private, proprietary control over data and opacity in how data are actually governed. 
For example, the private firm IMS purchases pharmacy data from pharmacy chains, insurance companies, 
and healthcare providers, aggregates the data, and resells the data to pharmaceutical firms (Tanner 2016), 
allowing all parties to monetize health data they govern. Pharmaceutical firms may then use the data to 
target physicians’ prescribing practices and justify patented drug prices with putative evidenced-based 
pricing – actions that may counter the public good of a more affordable health care system. 
Even when there is some alignment in values, stakeholder interests may differ, and hence generate 
conflicting approaches to data governance. Such conflicts are evident when the Organizational model 
overlaps with other PHI governance models, and data “leaks” between governance structures (See Figure 
1). Organizations generally seek to improve their own operational efficiencies and competitive positioning 
through PHI (in addition to providing better healthcare services). For health service providers, sharing 
information with competitors may not be in the organization’s economic interests. These conflicts are 
evident with the U.S. health information exchange (HIE) approach to data governance. There has been 
little sustained success among HIEs, despite investment and normative pressure from the U.S. Federal 
government, and recent complaints about “information blocking” practices have been lodged (Office of 
the National Coordinator for Health Information Technology 2015b; Eden et al 2016). By comparison, 
intra-organizational data sharing within health provider networks have flourished (Downing et al 2017). 
Similarly, the failure of institutional arrangements for clinical data sharing between health providers and 
personal health record firms contributed to the failure of the Google Health personal health record, 
whereas organizationally controlled patient portals, which allows individuals to view their PHI within the 
provider’s EHR system, have been more successful (Davidson et al, 2015). Thus, the governance goals of 
data-driven engagement are limited to the patient’s engagement with the EHR owner/provider. Finally, 
conflict between the Organizational and other governance models is evident between insurance 
companies, which mine their medical claims data for organizational performance improvement and the 
Public Good or Community Health model. In the U.S., private insurers have resisted recent federally 
mandated efforts to construct regional “all-payers claims” databases of de-identified health claims records 
for medical, public health, and public policy research based on claimed governance structures of 
intellectual property and data ownership (Freedman et al 2016). 
An emerging conflict between PHI data governance models is the use of personally generated health data 
from wearable devices as well as trace data generated by everyday activities that are IT-mediated, such as 
Internet browsing and mobile phone use. Advances in data analytics have allowed data scientists to 
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attribute health conditions to individuals based on these trace data. For instance, Microsoft researchers 
were able to use Internet search queries to identify individuals with pancreatic cancer prior to any disease 
diagnosis (Markoff 2016). Important governance questions are, for what purposes would such data be 
used and what governance structures and goals would determine these uses? Does governance of such 
data and the PHI profiles derived from them fall under the Aggregator model, and hence the stewardship 
of IT vendors or other private firms to monetize data as they see fit? Or, should data fall under the 
Personal model, so that individuals decide who can see their data and for what purposes? Today, because 
the individual is not aware what data have been collected or sold, or how big data algorithms will attribute 
health status, there is a lack of transparency and individuals have little voice in these decisions. 
Concluding remarks 
Few would question the value of PHI data to promote individual, population, and societal health or 
improvements in healthcare systems. Given the economic impact of the healthcare sector in the U.S. and 
globally, few would question the monetary value of these data either. Thus, there are many questions 
about how health data should be governed and for what goals. Here, we have argued that to better address 
questions of “how to” and “who” should govern health data stores, we need to consider which of the many 
potential values that PHI data represent and whose values and interests will be prioritized, or suppressed, 
by any specific governance model. Realizing value from governing PHI data is not a zero-sum game, as 
health data can be used and reused to support multiple forms of value creation. Neither is it necessarily a 
win-win situation, as the value(s) realized lie not in the data per se, but in the social and economic 
purposes and outcomes of data-inspired policies and practices. Also important are the resources 
committed to “extracting value” or mining PHI data. Will the “best and brightest” data scientists be 
dedicated to trolling “big health data” to improve the health and well being or to monetize PHI data? 
To better understand and thus to more effectively manage (or regulate) the complex, emergent, and 
networked nature of personal health data requires that we understand who are the stakeholders  in 
relation to personal health data and to identify their relevant interests (Kaanan and Carr 2009; 
Rosenbaum 2010). Our paper contributes to answering these questions by delving beneath important, 
high-level questions about health data privacy and security, and serving the public good through health 
data research, to consider how different arrangements of stakeholders, data value, governance structures 
and goals align around different models for PHI data governance. We identified and characterized six 
models and considered how underlying conflicts in stakeholder values and interests might disrupt socially 
desirable data governance and stewardship. 
This analysis is a starting point to facilitate further discussion. One limitation of our discourse analysis is 
that the six models reflect the mixed private-public funding and service delivery model in the U.S. 
Examining PHI governance models in single-payer sectors, as in Canada, and unified-payer/-provider 
sectors, as in the U.K. and elsewhere, could reveal other models and other tensions, conflicts, and 
potential governance structures. A next step in our ongoing research project will be to solicit feedback 
from stakeholders involved in these various models, such as medical researchers and private insurers 
among others. Case studies will also be useful to further detail governance models and to understand the 
processes through which specific instantiations of a model are initiated and evolve. Finally, our focus has 
been on the policy, social, and economic factors that influence data governance. Without question, health 
data are complex and health IT systems lack standardization, which presents significant challenges to 
data stewardship in terms of harmonizing and aggregating disparate sources of PHI. Blending a technical 
focus on the “how to” questions with an appreciation of social and organizational issues will better inform 
policy makers on how to promote PHI data governance structures and stewardship entities. 
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